TOKENPOST
1 min read
Add as a preferred source on Google

AstraZeneca Acquires Omniose, Adds Biotech to Its Infectious Disease Unit

Omniose announced the acquisition Tuesday, Nov. 10, and is now a wholly owned AstraZeneca subsidiary.

By John Kim
Published
Gloved hands prepare a culture plate inside a quiet laboratory / TokenPost.ai
Gloved hands prepare a culture plate inside a quiet laboratory / TokenPost.ai

Omniose has become a wholly owned subsidiary of AstraZeneca and part of its Infectious Disease Unit.

Omniose announced the acquisition Tuesday, Nov. 10.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…